About Solta Medical  | Board of Directors 

MEET OUR SEASONED GOVERNANCE TEAM  


Chairman of the Board, President and Chief Executive Officer

Stephen J. Fanning was appointed President and Chief Executive Officer of Solta Medical, Inc. (formerly Thermage, Inc.), a global leader in the medical aesthetics market, on January 15, 2005. He was elected Chairman of the Board of Directors effective July 31, 2006. Under his leadership, the Company went public in November 2006, raising $42 million. Also, in January 2009, he led the successful integration of the acquisition of Reliant Technologies, Inc., which combined the industry's two leading brands, Thermage® and Fraxel®, under a new corporate name of Solta Medical Inc., forming a global leader in aesthetic energy devices. In 2010, he led two additional successful integrations with the acquisition of Aesthera Corporation and CLRS Inc. bringing together the Isolaz® and CLARO® brands of products for the treatment of acne with Solta´s leading brands for skin tightening and skin resurfacing. Recently, under Mr. Fanning´s direction, Solta has announced it has reached an agreement for the acquisition of LIPOSONIX, a leading solution in the non-invasive destruction of fat, which will significantly broaden Solta's current market opportunity. Mr. Fanning has an extensive background in the healthcare, consumer pharmaceuticals and consumer package goods industries.

Mr. Fanning joined Thermage, Inc. from Ocular Sciences, Inc., a $350 million global public company, which developed, manufactured and marketed disposable contact lenses. Mr. Fanning had been President and Chief Executive Officer of the Company and a member of the Board of Directors since August 13, 2001. Under his leadership, Ocular Sciences implemented a next–generation manufacturing process, significantly driving down the cost of goods sold, achieved significant increases in global market share and attained more than $300 million in annual sales. In January 2005, Ocular Sciences was successfully acquired by CooperVision for $1.3 billion.

Mr. Fanning joined Ocular Sciences from Johnson & Johnson (J&J), one of the world´s largest manufacturers of healthcare products, where he served in various senior executive positions of escalating responsibility for 25 years. His most recent position was President, Worldwide, of J&J´s McNeil Specialty Products division. Prior to that, he served as President of Johnson & Johnson Medical, a medical device company. Mr. Fanning has also served as Managing Director of J&J Austria/Switzerland, and Vice President, Sales, of J&J´s McNeil Consumer Products Division.

Mr. Fanning holds a Bachelor of Science degree from Philadelphia University.

BACK TO TOP
Director

Harold ("Hal") Covert was nominated to our Board of Directors on July 11, 2007 and serves as Chairman of our Audit Committee. In September 2011, Mr. Covert was appointed Executive Vice President and Chief Financial Officer of Lumos Networks Corporation, a spinoff of a wireless service provider Ntelos Holdings Corp. In October 2007, Mr. Covert was appointed Chief Financial Officer of Silicon Image, a leader in the secure distribution, presentation and storage of high-definition content. From October 2005 to October 2007, Mr. Covert served as Chief Financial Officer of Openwave Systems, a provider of software solutions for the communications and media industries. From December 2003 to September 2005, Mr. Covert served as Chief Financial Officer of Fortinet, a security software company. From July 2001 to October 2003, Mr. Covert served as Chief Financial Officer of Extreme Networks, a network infrastructure equipment provider. Mr. Covert currently serves as a director of JDS Uniphase, a networking equipment manufacturer. Mr. Covert received his B.S. degree from Lake Erie College and his M.B.A. from Cleveland State University. Mr. Covert is a Certified Public Accountant.

BACK TO TOP
Director

Linda Graebner was nominated to the Board of Directors effective February 9, 2011 and serves on our Compensation Committee. Ms. Graenber is currently Managing Partner of LG Associates. From 1993 to 2006, Ms. Graebner was CEO of Tila. From 1987 to 1993 Ms. Graebner held various executive level positions at Dole Food Company. In 1979 to 1987 she held senior Marketing & Business Development as well as Strategic Planning positions at James River Corporation, and similar positions at Crown Zellerbach. From 1975 to 1979, Ms. Graebner was also a Senior Associate with the management consulting firm of Booz, Allen & Hamilton. Ms. Graebner is currently serving on several Boards: Distant Lands Coffee and Evriholder Products LLP (kitchen, cleaning and personal care). She has served as the Chairman of the Board of the International Housewares Association (IHA) and currently leads a Bay Area CEO Group sponsored by IHA. She also serves as Group Chair of the Silicon Valley Chapter of the Women Presidents' Organization and as a Chair of the Chief Executive Council in San Francisco. Ms. Graebner has a B.S. degree in mathematics from Purdue University and an M.B.A. from Stanford University.

BACK TO TOP
Founder, Director

Dr. Knowlton is the original founder of Thermage. His many accomplishments include the invention of the ThermaCool TC System. Dr. Knowlton is also an active Plastic Surgeon with 26 years of experience in private practice. He is the founder of the Danville Ambulatory Surgery Center, an outpatient Plastic Surgery Center of Excellence that was established in 1983. Dr. Knowlton graduated from the Washington University Medical School in St. Louis in 1973, completed his surgical residency in 1978, and was certified by the American Board of Plastic Surgery in 1981. He is the author of numerous patents in the medical device field and has written several scientific papers on Plastic Surgery including an innovative approach to breast reconstruction called the Peg Procedures.

BACK TO TOP
Director

Ms. McCarthy is President and Chief Executive Officer of CrossTack, Inc., a consulting firm providing highly experienced professionals to assist clients in developing strategies to address critical decisions by applying a project management framework and processes. From 2007 to 2011, Ms. McCarthy was President and Chief Executive Officer of SM&A, a provider of business strategy, competition management and project management consulting services to large government contractors in the aerospace and defense, healthcare, financial/audit and software industry. Ms. McCarthy served in various senior executive positions at SM&A including Executive Vice President & Chief Financial Officer, Corporate Secretary, and served as President and Chief Operating Officer from 2005 to 2007. Prior to SM&A, Ms. McCarthy was Chief Financial Officer of PIA Merchandising, a retail merchandising firm, Giant Group, Ltd, a Los Angeles investment firm and Wherehouse Entertainment, a major music and video retailer. Ms. McCarthy began her career at Mellon Bank, NA in Pittsburgh, Pennsylvania where she held various senior lending and credit approval positions in both the commercial lending and credit divisions of the bank, including Vice President of the Highly Leveraged Transaction Division of the bank's credit department.

Ms. McCarthy currently serves as Chairman of the Board of SM&A, is a member of the Orange County Advisory Board of City National Bank, is an advisory board member of a private company, the Clipper Corporation. Ms Mccarthy is a member of the Board of Governors of the Aerospace Industry Association, which focuses on supporting industry issues covering civil aviation, space, national security, and procurement and finance. Ms. McCarthy attended Robert Morris College and the University of Wisconsin at Madison´s banking program.

BACK TO TOP
Director

Mark M. Sieczkarek became a member of our Board of Directors in August 2006 and serves as our Lead Director and Chairman of our Compensation Committee. From April 2003 through December 2011, Mr. Sieczkarek served as President and Chief Executive Officer of Conceptus, Inc. and was a member of their Board of Directors. Previously, Mr. Sieczkarek was Senior Vice President and President of The Americas Region, responsible for the commercial operation of all Bausch & Lomb businesses in the United States, Canada and Latin America. Mark joined Bausch & Lomb in 1995 as Vice President and Controller in the former Personal Products division and also served as a Vice President in Corporate Business Development. Previously, Mark held executive level position with KOS Pharmaceuticals, several Bristol Myers-Squibb subsidiaries and Sanofi Diagnostics Pasteur. He received a MBA degree in Finance from Canisus College in Buffalo, NY., and a B.S. degree in Accounting from the State University of New York at Buffalo in 1976.

BACK TO TOP
Director

Eric B. Stang has been a member of our Board of Directors since December 2008 and he is Chairman of our Governance & Nominating Committee. Mr. Stang was appointed President and Chief Executive Officer of ooma, Inc. in January 2009. Mr. Stang possesses a wealth of leadership experience from company founder to corporate CEO, with a career including positions in consumer products, semiconductors, scientific computer and medical technology, strategic planning, and general management. From October 2006 to December 2008, Mr. Stang was Chief Executive Officer of Reliant, Technologies, a medical technology company, which was acquired by Solta Medical, Inc. (formerly Thermage, Inc.). Prior to Reliant Technologies, Mr. Stang was Chief Executive Officer, President, and Chairman of the Board of Directors for Lexar, now a subsidiary of Micron. Lexar is a leading provider of NAND flash memory products, including memory cards, USB flash drives, card readers and ATA controller technology for the digital photography, consumer electronics, industrial and communications markets. During his seven years at Lexar, Mr. Stang played a leadership role in taking the company public, effectively enacted a turnaround strategy, led its growth and entry into new markets, oversaw the development of a consumer brand, and established Lexar products in over 70,000 storefronts worldwide with 2005 revenues in excess of $850 million. Under Mr. Stang's leadership, Lexar became one of the 50 largest public technology companies in Silicon Valley before its acquisition by Micron.

Prior to Lexar, Mr. Stang was with ADAC Laboratories, where he led the company's worldwide radiation therapy planning business, which at the time was the company's fastest growing and most profitable division. In this role, Mr. Stang worked closely with luminary oncologists and medical physicists at several universities around the world in support of ADAC's technology leadership in radiation treatment planning. Mr. Stang also served as Vice President and General Manager of ADAC Laboratories.

Previously, he was Director of Operations at Raychem Corporation. Mr. Stang co-founded Monitor Company Europe Limited, an international strategic consulting firm in Europe. He has also worked for McKinsey & Company and as a software engineer at Ford Aerospace (now Loral). He holds a B.A. in economics from Stanford University and an M.B.A. from the Harvard Graduate School of Business at Harvard University. Additionally, Mr. Stang sits on the board of Miradia, a private company that designs and manufactures a micro-mirror array that drives high-performance, high- definition displays.

BACK TO TOP